Abstract

We postulate that exit from pluripotency involves intermediates that retain pluripotency while simultaneously exhibiting lineage-bias. Using a MIXL1 reporter, we explore mesoderm lineage-bias within the human pluripotent stem cell compartment. We identify a substate, which at the single cell level coexpresses pluripotent and mesodermal gene expression programmes. Functionally these cells initiate stem cell cultures and exhibit mesodermal bias in differentiation assays. By promoting mesodermal identity through manipulation of WNT signalling while preventing exit from pluripotency using lysophosphatidic acid, we ‘trap’ and maintain cells in a lineage-biased stem cell state through multiple passages. These cells correspond to a normal state on the differentiation trajectory, the plasticity of which is evidenced by their reacquisition of an unbiased state upon removal of differentiation cues. The use of ‘cross-antagonistic’ signalling to trap pluripotent stem cell intermediates with different lineage-bias may have general applicability in the efficient production of cells for regenerative medicine.

Application of pluripotent cells in regenerative medicine requires an understanding of how they exit pluripotency. Here the authors demonstrate support for the idea that pluripotency exit involves pluripotent intermediates that exhibit lineage bias by identifying and trapping a mesoderm biased sub-state in culture.

Details

Title
Generation and trapping of a mesoderm biased state of human pluripotency
Author
Stavish Dylan 1   VIAFID ORCID Logo  ; Böiers Charlotta 2   VIAFID ORCID Logo  ; Price, Christopher 1   VIAFID ORCID Logo  ; Frith, Thomas J, R 1   VIAFID ORCID Logo  ; Halliwell, Jason 1   VIAFID ORCID Logo  ; Saldaña-Guerrero, Ingrid 1   VIAFID ORCID Logo  ; Wray, Jason 2 ; Brown, John 2   VIAFID ORCID Logo  ; Carr, Jonathon 1 ; Chela, James 2 ; Barbaric Ivana 1 ; Andrews, Peter W 1   VIAFID ORCID Logo  ; Enver Tariq 2 

 University of Sheffield, Western Bank, The Centre for Stem Cell Biology, Department of Biomedical Science, Sheffield, UK (GRID:grid.11835.3e) (ISNI:0000 0004 1936 9262) 
 University College London Cancer Institute, Stem Cell Laboratory, Department of Cancer Biology, London, UK (GRID:grid.83440.3b) (ISNI:0000000121901201) 
Publication year
2020
Publication date
2020
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2449451836
Copyright
© The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.